These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34387015)

  • 41. Identification of Bostrycin Derivatives as Potential Inhibitors of Mycobacterium tuberculosis Protein Tyrosine Phosphatase (MptpB).
    Chen DN; Chen H; She ZG; Lu YJ
    Med Chem; 2016; 12(3):296-302. PubMed ID: 26434800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GPS-PUP: computational prediction of pupylation sites in prokaryotic proteins.
    Liu Z; Ma Q; Cao J; Gao X; Ren J; Xue Y
    Mol Biosyst; 2011 Oct; 7(10):2737-40. PubMed ID: 21850344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acetate Kinase (AcK) is Essential for Microbial Growth and Betel-derived Compounds Potentially Target AcK, PhoP and MDR Proteins in M. tuberculosis, V. cholerae and Pathogenic E. coli: An in silico and in vitro Study.
    Tiwari S; Barh D; Imchen M; Rao E; Kumavath RK; Seenivasan SP; Jaiswal AK; Jamal SB; Kumar V; Ghosh P; Azevedo V
    Curr Top Med Chem; 2018; 18(31):2731-2740. PubMed ID: 30663567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allosteric transitions direct protein tagging by PafA, the prokaryotic ubiquitin-like protein (Pup) ligase.
    Ofer N; Forer N; Korman M; Vishkautzan M; Khalaila I; Gur E
    J Biol Chem; 2013 Apr; 288(16):11287-93. PubMed ID: 23471967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The regulatory significance of tag recycling in the mycobacterial Pup-proteasome system.
    Elharar Y; Schlussel S; Hecht N; Meijler MM; Gur E
    FEBS J; 2017 Jun; 284(12):1804-1814. PubMed ID: 28440944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of pupylation of Streptomyces hygroscopicus 5008 in vitro.
    Xu X; Niu Y; Liang K; Shen G; Cao Q; Yang Y
    Biochem Biophys Res Commun; 2016 May; 474(1):126-130. PubMed ID: 27105915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth.
    Chollet A; Mori G; Menendez C; Rodriguez F; Fabing I; Pasca MR; Madacki J; Korduláková J; Constant P; Quémard A; Bernardes-Génisson V; Lherbet C; Baltas M
    Eur J Med Chem; 2015 Aug; 101():218-35. PubMed ID: 26142487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
    Saharan VD; Mahajan SS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ubiquitin-like protein involved in the proteasome pathway of Mycobacterium tuberculosis.
    Pearce MJ; Mintseris J; Ferreyra J; Gygi SP; Darwin KH
    Science; 2008 Nov; 322(5904):1104-7. PubMed ID: 18832610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deciphering Molecular Virulence Mechanism of Mycobacterium tuberculosis Dop isopeptidase Based on Its Sequence-Structure-Function Linkage.
    Prathiviraj R; Chellapandi P
    Protein J; 2020 Feb; 39(1):33-45. PubMed ID: 31760575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transition State Analogue Inhibitors of 5'-Deoxyadenosine/5'-Methylthioadenosine Nucleosidase from Mycobacterium tuberculosis.
    Namanja-Magliano HA; Evans GB; Harijan RK; Tyler PC; Schramm VL
    Biochemistry; 2017 Sep; 56(38):5090-5098. PubMed ID: 28836767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of bicyclic inhibitors against menaquinone biosynthesis.
    Choi SR; Larson MA; Hinrichs SH; Bartling AM; Frandsen J; Narayanasamy P
    Future Med Chem; 2016 Jan; 8(1):11-6. PubMed ID: 26699277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacterial ubiquitin-like modifier Pup is deamidated and conjugated to substrates by distinct but homologous enzymes.
    Striebel F; Imkamp F; Sutter M; Steiner M; Mamedov A; Weber-Ban E
    Nat Struct Mol Biol; 2009 Jun; 16(6):647-51. PubMed ID: 19448618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mycobacterium tuberculosis prokaryotic ubiquitin-like protein-deconjugating enzyme is an unusual aspartate amidase.
    Burns KE; McAllister FE; Schwerdtfeger C; Mintseris J; Cerda-Maira F; Noens EE; Wilmanns M; Hubbard SR; Melandri F; Ovaa H; Gygi SP; Darwin KH
    J Biol Chem; 2012 Oct; 287(44):37522-9. PubMed ID: 22942282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prokaryotic ubiquitin-like protein provides a two-part degron to Mycobacterium proteasome substrates.
    Burns KE; Pearce MJ; Darwin KH
    J Bacteriol; 2010 Jun; 192(11):2933-5. PubMed ID: 20233925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-Based Optimization of Pyridoxal 5'-Phosphate-Dependent Transaminase Enzyme (BioA) Inhibitors that Target Biotin Biosynthesis in Mycobacterium tuberculosis.
    Liu F; Dawadi S; Maize KM; Dai R; Park SW; Schnappinger D; Finzel BC; Aldrich CC
    J Med Chem; 2017 Jul; 60(13):5507-5520. PubMed ID: 28594172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fate of pup inside the Mycobacterium proteasome studied by in-cell NMR.
    Maldonado AY; Burz DS; Reverdatto S; Shekhtman A
    PLoS One; 2013; 8(9):e74576. PubMed ID: 24040288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan H; Doğan ŞD; Gündüz MG; Krishna VS; Lherbet C; Sriram D; Şahin O; Sarıpınar E
    Eur J Med Chem; 2020 Feb; 188():112035. PubMed ID: 31951850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.